Disease modifying agents in Parkinson's disease?

被引:0
|
作者
Schapira, A. H. V. [1 ]
机构
[1] Inst Neurol, London WC1N 3BG, England
关键词
D O I
10.1016/S0022-510X(09)70217-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S46 / S46
页数:1
相关论文
共 50 条
  • [1] Parkinson's disease subtypes and their relevance to studies of disease-modifying agents
    Elm, J.
    Bergmann, K.
    Tilley, B.
    Goudreau, J.
    Salak, V.
    Weiner, W.
    Aminoff, M.
    Shulman, L.
    Cambi, F.
    Kieburtz, K.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S61 - S61
  • [2] Disease-modifying drugs and Parkinson's disease
    Allain, Herve
    Bentue-Ferrer, Daniele
    Akwa, Yvette
    PROGRESS IN NEUROBIOLOGY, 2008, 84 (01) : 25 - 39
  • [3] Disease-Modifying Drugs in Parkinson’s Disease
    Ariane Park
    Mark Stacy
    Drugs, 2015, 75 : 2065 - 2071
  • [4] Disease-Modifying Drugs in Parkinson's Disease
    Park, Ariane
    Stacy, Mark
    DRUGS, 2015, 75 (18) : 2065 - 2071
  • [5] Disease-Modifying Strategies for Parkinson's Disease
    Kalia, Lorraine V.
    Kalia, Suneil K.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2015, 30 (11) : 1442 - 1450
  • [6] PARKINSON'S DISEASE; TOWARDS NEW DISEASE MODIFYING THERAPIES
    Finkelstein, D. I.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 : 1 - 1
  • [7] Challenges of modifying disease progression in prediagnostic Parkinson's disease
    Salat, David
    Noyce, Alastair J.
    Schrag, Anette
    Tolosa, Eduardo
    LANCET NEUROLOGY, 2016, 15 (06): : 637 - 648
  • [8] Promising disease-modifying therapies for Parkinson's disease
    Dawson, Valina L.
    Dawson, Ted M.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (520)
  • [9] Multitarget disease-modifying therapy in Parkinson's disease?
    Calabresi, Paolo
    Di Filippo, Massimiliano
    LANCET NEUROLOGY, 2015, 14 (10): : 975 - 976
  • [10] PARKINSON'S DISEASE; TOWARDS NEW DISEASE MODIFYING THERAPIES
    Wu, K.
    Su, W.
    Wen, B.
    Zhang, Y.
    Wang, T.
    Zhang, L.
    Wang, P.
    Wang, J.
    Liu, L.
    Chen, C.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 : 1 - 1